CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


United Cannabis Corp  (CNAB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CNAB's Revenue Growth by Quarter and Year

United Cannabis's Revenue results by quarter and year




CNAB Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -0.09 0.26 0.13
III Quarter September 2.13 0.10 0.20 0.31
II Quarter June 1.86 0.16 0.25 0.09
I Quarter March 0.27 0.19 - 0.10
FY   4.26 0.36 0.71 0.63



CNAB Revenue third quarter 2018 Y/Y Growth Comment
United Cannabis Corp achieved in the third quarter, above Company average Revenue surge of 2032.3% year on year, to $ 2.13 millions.

Among companies who have reported third quarter results in the Biotechnology & Drugs industry only one Company has achieved higher year on year Revenue results in the third quarter. While United Cannabis Corp' s Revenue doubling of 2032.3% ranks overall at the positon no. 13 in the third quarter.




CNAB Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - 100 % 44.44 %
III Quarter September 2032.3 % -50 % -35.48 % -
II Quarter June 1062.5 % -36 % 177.78 % -
I Quarter March 42.11 % - - -
FY   - -49.3 % 12.7 % -

Financial Statements
United Cannabis's third quarter 2018 Revenue $ 0.00 millions CNAB's Income Statement
United Cannabis's third quarter 2017 Revenue $ 0.00 millions Quarterly CNAB's Income Statement
New: More CNAB's historic Revenue Growth >>


CNAB Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - 30 % -58.06 %
III Quarter September 14.64 % -37.5 % -20 % 244.44 %
II Quarter June 588.89 % -15.79 % - -10 %
I Quarter March - -26.92 % - 11.11 %
FY (Year on Year)   - -49.3 % 12.7 % -




Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #2
Healthcare Sector #9
Overall #13

Revenue Y/Y Growth Statistics
High Average Low
1977.05 % 285.02 % -100 %
(Sep 30 2018)   (Dec 31 2015)
Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #2
Healthcare Sector #9
Overall #13
Revenue Y/Y Growth Statistics
High Average Low
1977.05 % 285.02 % -100 %
(Sep 30 2018)   (Dec 31 2015)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

United Cannabis's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
599.21 % 60.97 % -100 %
(Jun 30 2018)  


CNAB's III. Quarter Q/Q Revenue Comment
United Cannabis Corp achieved in the III. Quarter 2018 below company average Revenue rise of 14.64% quarter on quarter, to $ 2.13 millions.

Even if the III. Quarter 2018 United Cannabis's performance was below the regular , that has been yet promising story, as the III. Quarter improvement, eclipses the -37.5% Revenue surge in the III. Quarter a year ago

Within Biotechnology & Drugs industry 21 other companies have achieved higher Revenue quarter on quarter growth. While United Cannabis's Revenue growth quarter on quarter, overall rank is 406.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #22
Healthcare Sector #66
Overall #406
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #22
Healthcare Sector #66
Overall #406
Revenue Q/Q Growth Statistics
High Average Low
599.21 % 60.97 % -100 %
(Jun 30 2018)  


CNAB's III. Quarter Q/Q Revenue Comment
United Cannabis Corp achieved in the III. Quarter 2018 below company average Revenue rise of 14.64% quarter on quarter, to $ 2.13 millions.

Although the III. Quarter 2018 United Cannabis's performance was lower than the ordinary , it has been yet good sign, as the current improvement, outshines the -37.5% Revenue rise in the same quarter a year ago

Within Biotechnology & Drugs industry 21 other companies have achieved higher Revenue quarter on quarter growth. While United Cannabis's Revenue growth quarter on quarter, overall rank is 406.


United Cannabis's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Revenue 12 Months Ending $ 4.17 $ 2.14 $ 0.44 $ 0.36 $ 0.72
Y / Y Revenue Growth (TTM) 477.5 % 161.81 % -51.09 % - -
Year on Year Revenue Growth Overall Ranking # 39 # 123 # 3166 # 0 # 0
Seqeuential Revenue Change (TTM) 94.99 % 386.79 % 21.14 % -49.78 % -11.6 %
Seq. Revenue Growth (TTM) Overall Ranking # 16 # 11 # 243 # 4068 # 3886




Cumulative Revenue growth Comment
With 477.5% annual Revenue growth, United Cannabis Corp would report a record annual Revenue surge if the fiscal year would end on Sep 30 2018.

Among companies within the Healthcare sector 12 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 39, from total ranking in previous quarter at 123.

Revenue TTM Q/Q Growth Statistics
High Average Low
386.79 %
62.81 %
-49.78 %
(Jun 30 2018)  

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 0
Healthcare Sector # 13
Overall # 39

Revenue TTM Y/Y Growth Statistics
High Average Low
477.5 %
196.07 %
-51.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 10
S&P 500 # 16
Cumulative Revenue growth Comment
With 477.5% annual Revenue growth, United Cannabis Corp would report a record annual Revenue surge if the fiscal year would end on Sep 30 2018.

Among companies within the Healthcare sector 12 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 39, from total ranking in previous quarter at 123.

Revenue TTM Q/Q Growth Statistics
High Average Low
386.79 %
62.81 %
-49.78 %
(Jun 30 2018)  


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 0
Healthcare Sector # 13
Overall # 39

Revenue TTM Y/Y Growth Statistics
High Average Low
477.5 %
196.07 %
-51.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 10
S&P 500 # 16


You need to upgrade your Flash Player




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CNAB's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CNAB's Competitors
Revenue Growth for United Cannabis's Suppliers
Revenue Growth for CNAB's Customers

You may also want to know
CNAB's Annual Growth Rates CNAB's Profitability Ratios CNAB's Asset Turnover Ratio CNAB's Dividend Growth
CNAB's Roe CNAB's Valuation Ratios CNAB's Financial Strength Ratios CNAB's Dividend Payout Ratio
CNAB's Roa CNAB's Inventory Turnover Ratio CNAB's Growth Rates CNAB's Dividend Comparisons



Companies with similar Revenue surge for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2018
Revance Therapeutics, Inc.  3,049.33 %$ 3,049.333 millions
Transenterix Inc.  2,862.84 %$ 2,862.842 millions
Dynavax Technologies Corp  2,656.60 %$ 2,656.604 millions
United Cannabis Corp  1,977.05 %$ 1,977.053 millions
Synlogic, Inc.  1,522.52 %$ 1,522.523 millions
Bioscrip, Inc.  1,277.61 %$ 1,277.605 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SND's Profile

Stock Price

SND's Financials

Business Description

Fundamentals

Charts & Quotes

SND's News

Suppliers

SND's Competitors

Customers & Markets

Economic Indicators

SND's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071